- Home
- PRTA vs KRNY Comparison
PRTA vs KRNY Comparison
Compare PRTA & KRNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRTA | KRNY |
|---|---|---|
| Founded | 2012 | 1884 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.3M | 478.5M |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | PRTA | KRNY |
|---|---|---|
| Price | $9.78 | $7.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $19.00 | $8.00 |
| AVG Volume (30 Days) | ★ 383.0K | 264.2K |
| Earning Date | 05-20-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 5.91% |
| EPS Growth | N/A | ★ 130.22 |
| EPS | N/A | ★ 0.30 |
| Revenue | $814,000.00 | ★ $2,580,000.00 |
| Revenue This Year | $1,111.38 | $3.89 |
| Revenue Next Year | N/A | $17.52 |
| P/E Ratio | ★ N/A | $24.73 |
| Revenue Growth | N/A | ★ 36.00 |
| 52 Week Low | $4.32 | $5.45 |
| 52 Week High | $14.60 | $8.50 |
Technical Indicators
Market Signals| Indicator | PRTA | KRNY |
|---|---|---|
| Relative Strength Index (RSI) | 60.48 | 36.60 |
| Support Level | $9.54 | $7.40 |
| Resistance Level | $10.72 | $8.42 |
| Average True Range (ATR) | 0.55 | 0.27 |
| MACD | 0.11 | -0.07 |
| Stochastic Oscillator | 85.94 | 20.86 |
Price Performance
Historical ComparisonAbout PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.